Advertisement

Topics

Lilly Receives Priority Review for Advanced Breast Cancer Therapy

09:52 EDT 10 Jul 2017 | PharmPro

FDA grants priority review for Lilly's abemaciclib for the treatment of advanced breast cancer. Advanced breast cancer includes metastatic breast cancer that has spread to other parts of the body and locally or regionally advanced breast cancer.
Contributed Author: 
Eli Lilly and Company

Original Article: Lilly Receives Priority Review for Advanced Breast Cancer Therapy

NEXT ARTICLE

More From BioPortfolio on "Lilly Receives Priority Review for Advanced Breast Cancer Therapy"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...